| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/23/1993 | CA2076558A1 Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes |
| 02/23/1993 | CA1313816C Anthelmintic active compound combinations |
| 02/22/1993 | CA2076509A1 Hexahydrobenzo[f]quinolinones |
| 02/22/1993 | CA2076479A1 Benzo ¬f| quinolinones |
| 02/18/1993 | WO1993003059A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
| 02/18/1993 | WO1993003056A1 Lanthionine bridged peptides |
| 02/18/1993 | WO1993003050A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | WO1993003041A1 Geneserine derivatives as cholinesterase inhibitors |
| 02/18/1993 | WO1993003018A1 Compounds having angiotensine ii antagonistic activity |
| 02/18/1993 | WO1993003016A1 Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists |
| 02/18/1993 | WO1993003012A1 Indole derivatives |
| 02/18/1993 | WO1993002703A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | WO1993002699A1 Use of collagen for the treatment of degenerative joint ailments |
| 02/18/1993 | WO1993002677A1 5-ht4 receptor antagonists |
| 02/18/1993 | CA2115250A1 Geneserine derivatives as cholinesterase inhibitors |
| 02/18/1993 | CA2115246A1 Lanthionine bridged peptides |
| 02/18/1993 | CA2114942A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | CA2114934A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | CA2114621A1 Compounds having angiotensine ii antagonistic activity |
| 02/17/1993 | EP0527646A1 New compounds named the adenophostins, their preparation and their therapeutic use |
| 02/17/1993 | EP0527624A2 Use of a selective inhibitor of neutral endopeptidase and an angiotensin converting enzyme inhibitor in the preparation of a pharmaceutical for treating congestive heart failure |
| 02/17/1993 | EP0527540A1 Medicament for the treatment of withdrawal symptoms |
| 02/17/1993 | EP0527181A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase |
| 02/17/1993 | EP0527175A1 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists |
| 02/17/1993 | CA2076204A1 Hiv protease inhibitors with n-terminal polyether substituents |
| 02/17/1993 | CA2076149A1 Potentiation of antitussive effect of dextromethorphan |
| 02/17/1993 | CA2075666A1 Hiv protease inhibitors useful for the treatment of aids |
| 02/17/1993 | CA2067265A1 17.beta.-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5.alpha.-reductase inhibitors |
| 02/16/1993 | US5187286 Antiinflammatory agents, antiallergens |
| 02/16/1993 | US5187180 (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| 02/16/1993 | US5187164 Psychological disorders, antiemetics |
| 02/16/1993 | US5187159 Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole |
| 02/16/1993 | US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| 02/16/1993 | US5187089 Variants wherein there are nonpolar amino acid substitutions at the substrate binding site |
| 02/16/1993 | CA2076191A1 Therapeutic compounds |
| 02/16/1993 | CA2076146A1 Piperidine derivatives |
| 02/16/1993 | CA1313622C Pharmaceutical composition containing 17.beta.oestradiol and desogestr el |
| 02/13/1993 | CA2075671A1 Treatment of congestive heart failure |
| 02/10/1993 | WO1993002684A1 β-GLUCURONIDASE INHIBITOR |
| 02/10/1993 | EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526877A2 Peptide aldehydes as antithrombotic agents |
| 02/10/1993 | EP0526756A1 Composition for revitalizing scar tissue |
| 02/10/1993 | EP0526630A1 Use of gm-csf and g-csf to promote accelerated wound healing |
| 02/10/1993 | EP0526608A1 Therapeutic agents for the treatment of multidrug resistance to cancers. |
| 02/10/1993 | EP0526578A1 Composition and method for topical treatment of damaged or diseased tissue |
| 02/10/1993 | EP0526545A1 Isoquinoline amides and esters as 5 ht3 receptor antagonists |
| 02/10/1993 | EP0526544A1 Therapeutic uses of actin-binding compounds |
| 02/10/1993 | EP0409881B1 N-heterocyclic propylidene-1,1-bisphosphonic acids, their production and a pharmaceutical composition |
| 02/10/1993 | CN1068817A Indole derivatives |
| 02/10/1993 | CN1068816A Indoles |
| 02/10/1993 | CN1019890C Process for preparation of 4-heterocyclic sulfonyl (or thio-) propyl-oxy-2-hydroxy-3-propyl-hypnone derivatives |
| 02/10/1993 | CN1019889C Process for preparing urea derivatives |
| 02/10/1993 | CA2093442A1 B-glucuronidase inhibitor |
| 02/10/1993 | CA2088518A1 Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
| 02/10/1993 | CA2075612A1 Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
| 02/09/1993 | US5185377 Applying locally or by inhalation as antiinflammatory agent, antiallergen, bronchodilator, antiasthmatic, antipsoriatic |
| 02/09/1993 | US5185361 Pharmaceutical compounds |
| 02/09/1993 | US5185352 Alkoxy-4(1h)-pyridone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 02/09/1993 | US5185324 Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof |
| 02/09/1993 | CA2075459A1 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as hmg-coa reductase inhibitors |
| 02/09/1993 | CA2074699A1 Neristatin 1 |
| 02/09/1993 | CA1313500C Pharmaceutical compositions for the treatment of occlusive vascular diseases |
| 02/07/1993 | CA2075154A1 Peptide aldehydes as antithrombotic agents |
| 02/04/1993 | WO1993002203A1 Fr901451 substance, process for preparation thereof and use thereof |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002188A1 Universal donor cells |
| 02/04/1993 | WO1993002185A1 Acat inhibitor |
| 02/04/1993 | WO1993002099A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 02/04/1993 | WO1993002051A1 Indoles |
| 02/04/1993 | WO1993002050A1 Indoles |
| 02/04/1993 | WO1993001819A1 Use of silicon compounds for preventing traumatic injuries |
| 02/04/1993 | WO1993001813A1 Platelet activating factor antagonists |
| 02/04/1993 | WO1993001812A1 S-(3-(4(5))-imidazolyl)propyl)isothiourea as selective trhistomine h3 receptor antagonist |
| 02/04/1993 | WO1992018475A3 Substituted phenylazacycloalkanes as cns agents |
| 02/04/1993 | DE4125400A1 Verwendung von kollagen zur behandlung von degenerativen gelenkprozessen Use of collagen for the treatment of degenerative joint processes |
| 02/04/1993 | CA2113358A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2112689A1 Indoles |
| 02/04/1993 | CA2112678A1 Indoles |
| 02/04/1993 | CA2112562A1 Platelet activating factor antagonists |
| 02/04/1993 | CA2111972A1 Prevention and reduction of severity of traumatic injury |
| 02/03/1993 | EP0526434A1 Benzimidazolone derivatives as 5-HT1A and 5-HT2 antagonists |
| 02/03/1993 | EP0526402A1 Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors |
| 02/03/1993 | EP0526395A1 Arylalkylamine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526200A1 2-(Imidazol-1-YL)-2-benzyl-ethylidene-aminoxyalkanoic acid derivatives as thromboxane A2 inhibitors |
| 02/03/1993 | EP0526192A2 Hexapeptide |
| 02/03/1993 | EP0526009A1 Inhibitors of hiv protease useful for the treatment of aids |
| 02/03/1993 | EP0526001A1 Substituted triazolinones |
| 02/03/1993 | EP0525973A2 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 02/03/1993 | EP0525885A1 New sulphur containing nonsteroidal drugs as 5-alpha reductase inhibitors |
| 02/03/1993 | EP0525629A2 5-membered heterocycles, process for their preparation and medicaments containing them |
| 02/03/1993 | EP0525584A1 6-Oxo-azepinoindole derivatives, process and intermediates for their preparation and medicaments containing them |
| 02/03/1993 | EP0525571A1 Quinolin-2-yl-methoxybenzylhydroxyureas as lipoxygenase inhibitors |
| 02/03/1993 | EP0525570A2 Anti-idiotypic antibodies that mimic TNF |
| 02/03/1993 | EP0525472A2 Methylen-oxindole derivatives and process for their preparation |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
| 02/03/1993 | EP0525129A1 Substituted benzimidazoles |
| 02/03/1993 | EP0525109A1 Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase |
| 02/03/1993 | EP0525054A1 Modified heparin binding growth factors |